Latest & greatest articles for schizophrenia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on schizophrenia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on schizophrenia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for schizophrenia

81. Mind-body therapies for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials

Mind-body therapies for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

82. Health utilities values in schizophrenia: systematic review and meta-analysis

Health utilities values in schizophrenia: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

83. Effectiveness of Assertive Community Treatment for schizophrenia in China: a systematic review and meta-analysis

Effectiveness of Assertive Community Treatment for schizophrenia in China: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

84. Employment programs for schizophrenia in psychosocial rehabilitation: a systematic review

Employment programs for schizophrenia in psychosocial rehabilitation: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

85. The effectiveness of psychoeducational interventions for patients with schizophrenia: a systematic review

The effectiveness of psychoeducational interventions for patients with schizophrenia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

86. Worldwide prevalence of smoking cessation in schizophrenia patients: a meta-analysis of comparative and observational studies

Worldwide prevalence of smoking cessation in schizophrenia patients: a meta-analysis of comparative and observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

87. Treatment effects on neurometabolite levels in schizophrenia: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies

Treatment effects on neurometabolite levels in schizophrenia: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

88. Voluntary and involuntary admissions in patients with schizophrenia: a systematic review and meta-analysis

Voluntary and involuntary admissions in patients with schizophrenia: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

89. Plasmatic cytokines levels in high risk of schizophrenia subjects: a meta-analysis and review

Plasmatic cytokines levels in high risk of schizophrenia subjects: a meta-analysis and review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

90. Psychosocial family interventions for relatives of people living with schizophrenia in the Arab world: a systematic review

Psychosocial family interventions for relatives of people living with schizophrenia in the Arab world: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

91. Meta-analysis of structural magnetic resonance imaging findings in people at ultra-high risk of psychosis, first-episode psychosis or established schizophrenia

Meta-analysis of structural magnetic resonance imaging findings in people at ultra-high risk of psychosis, first-episode psychosis or established schizophrenia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

92. Hypothalamic-pituitary-adrenal axis related genes and cognition in major mood disorders and schizophrenia: a systematic review

Hypothalamic-pituitary-adrenal axis related genes and cognition in major mood disorders and schizophrenia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

93. Neural correlates of theory of mind and empathy in schizophrenia: an activation likelihood estimation meta-analysis

Neural correlates of theory of mind and empathy in schizophrenia: an activation likelihood estimation meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

94. Association between schizophrenia and risk of sexual dysfunction: a meta-analysis

Association between schizophrenia and risk of sexual dysfunction: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

95. Mindfulness-based interventions for people with schizophrenia: a meta-analysis

Mindfulness-based interventions for people with schizophrenia: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

96. Long term effects of low-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with auditory verbal hallucinations: a meta-analysis

Long term effects of low-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with auditory verbal hallucinations: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

97. A review of mental health diagnoses during the prodrome of schizophrenia

A review of mental health diagnoses during the prodrome of schizophrenia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

98. Adherence therapy for schizophrenia: a randomised controlled trial. (Abstract)

Adherence therapy for schizophrenia: a randomised controlled trial. 30674700 2019 01 24 1024-2708 25 Suppl 2 2019 Feb Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Adherence therapy for schizophrenia: a randomised controlled trial. 4-9 Chien W T WT Nethersole School of Nursing, The Chinese University of Hong Kong. Cheung E Fc EF Castle Peak Hospital, Hospital Authority, Hong Kong. Mui J Hc JH Castle Peak Hospital, Hospital Authority, Hong Kong. Gray R R Faculty of Medicine

2019 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: predicted high

99. Effectiveness of a community-based intervention for patients with schizophrenia: study protocol for a systematic review and meta-analysis

Effectiveness of a community-based intervention for patients with schizophrenia: study protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

100. Pharmacological interventions: Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t)

Pharmacological interventions: Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t) Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t) | Evidence-Based Mental Health Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t) Article Text Commentary Pharmacological interventions Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t) Marco Solmi 1 , 2 , Christoph U Correll 3 , 4 , 5 , 6 Statistics from Altmetric.com Commentary

2019 Evidence-Based Mental Health